The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

The administration in May canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans. When asked about the uncertain regulatory environment in the U.S., ...

Warren and Duckworth demanded Kennedy make the review public, alongside a similar review the department cited when it cut ...

US Senate Democrats demand Kennedy explain canceling bird flu vaccine contract - Nation and World News | Hawaii ...

WASHINGTON >> U.S. Senate Democrats demanded today that Health Secretary Robert F. Kennedy Jr. make public the reviews on ...

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...